Press release
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”
For more information please click on the following https://www.rootsanalysis.com/reports/253/request-sample.html:
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an in-depth analysis, highlighting the capabilities of the various companies engaged in this domain. Amongst various elements, the report includes:
A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies.
An analysis of the landscape of companies offering testing services for cancer biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and FOXP3+).
An insightful 2X2 representation of the results of a detailed competitiveness analysis of various tests (segregated across different biomarker groups).
Elaborate profiles of leading analytical testing service providers focused on immuno-oncology biomarkers (shortlisted based on strength of service portfolio).
A detailed publication analysis of over 180 research articles that have been published since 2016, highlighting the key focus areas of ongoing research activity related to immuno-oncology biomarkers, namely TMB, MSI / MMR and TILs.
A comprehensive clinical trial analysis of completed, ongoing and planned studies, focused on the assessment of cancer biomarkers, namely TMB, MSI / MMR and TILs.
A discussion on the upcoming opportunities that are likely to impact the evolution of this market over the coming years.
A discussion on various steps involved in development operations of companion diagnostics
A comparative analysis of the needs of different stakeholders involved in the development of companion diagnostic products
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of test
Laboratory Developed Tests (LDTs)
Companion Diagnostic Tests (CDx)
Type of disease indication
Breast cancer
Blood cancer
Colon / Colorectal cancer
Lung Cancer
Melanoma
Prostate Cancer
Type of cancer biomarker
TMB
MSI / MMR
TILs
Type of analytical technique
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Others
Key geographical regions
North America
Europe
Japan
China
Australia
Key companies covered in the report
Foundation Medicine
NeoGenomics Laboratories
Novogene
Q2 Solutions
Personal Genome Diagnostics
Dr Lal PathLabs
Shenzhen Yuce Biotechnology
For more information please click on the following https://www.rootsanalysis.com/reports/253/request-sample.html:
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
Other Recent Offerings
1. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030
2. Neoantigen Targeted Therapies Market, 2019-2030
3. Companion Diagnostics Market (2nd Edition), 2019-2030
4. Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030
5. In Vitro ADME Testing Services Market, 2019-2030
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis here
News-ID: 2253166 • Views: …
More Releases from Roots Analysis
Dental 3D Printing Market to Reach $15.8 Billion by 2035, Growing at 13.5% CAGR …
The global dental 3D printing market, valued at USD 4.1 billion in 2025, will grow to USD 5.0 billion in 2026 and reach USD 15.8 billion by 2035, advancing at a CAGR of 13.5% across the forecast period. This growth reflects accelerating adoption of additive manufacturing across dental laboratories, prosthodontic clinics, and orthodontic practices worldwide, driven by a chronic and worsening global burden of oral disease. For investors, technology developers,…
Deep Learning in Drug Discovery and Diagnostics Market to Reach $34.5 Billion by …
The global deep learning in drug discovery and diagnostics market, valued at USD 6.4 billion in 2025, will grow to USD 8.2 billion in 2026 and reach USD 34.5 billion by 2035, advancing at a compound annual growth rate of 17.3% over the forecast period. This expansion reflects accelerating adoption of neural network-based technologies across pharmaceutical R&D and clinical diagnostics, as more than 200 companies compete to bring AI-native solutions…
3D Cell Culture Market to Reach USD 8.90 Billion by 2035, Growing at 14.6% CAGR …
The global 3D cell culture market, valued at USD 2.16 billion in 2025 and projected to reach USD 2.61 billion in 2026, will grow to USD 8.90 billion by 2035, compounding at 14.6% annually over the forecast period. This growth reflects a fundamental shift in biomedical research methodology, as pharmaceutical companies, academic institutions, and contract research organizations accelerate their adoption of three-dimensional cell models to replace conventional animal testing and…
3D Bioprinting Market to Reach $23.1 Billion by 2035 at 17.7% CAGR | Stratasys, …
The global 3D bioprinting market, valued at USD 4.0 billion in 2024, is on course to reach USD 4.6 billion in 2025 and USD 23.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 17.7% over the forecast period. This sharp growth trajectory reflects intensifying demand across regenerative medicine, tissue engineering, and pharmaceutical drug development, as clinical researchers and biopharmaceutical companies accelerate adoption of bioprinting platforms capable…
More Releases for TMB
Fifosys Acquires TMB To Expand Service Offerings
Image: https://www.getnews.info/wp-content/uploads/2024/05/1716633175.jpeg
London, UK - 27 May, 2024 - Fifosys, a global leader in managed IT services, is excited to announce the acquisition of TMB (Technology Means Business). This strategic move aims to enhance Fifosys' service offerings and further solidify its position in the IT industry.
The acquisition is significant for Fifosys, as it's the third they have made in the last five years - and their second outside of London after…
Trimethyl Borate (TMB) Market: Size, Share, Growth, Analysis, Key Players, Reven …
Trimethyl Borate (TMB) Market
Trimethyl Borate is a colorless transparent liquid, stable in dry air, the water is decomposed into methanol and boric acid, and ethers, tetrahydrofuran, isopropyl amine, n-hexane, methanol and other organic solvent mixture, Specific gravity0.915, Boiling point67-68 ℃, and methanol to form azeotrope.
The global Trimethyl Borate (TMB) market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate…
Trimethyl Borate (TMB) Market Analysis and Future Prospects for 2030
The world of the trimethyl borate (tmb) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
Global Trimethyl Borate (TMB) Market Insights, Forecast to 2029
Trimethyl Borate (TMB) Market
Trimethyl Borate is a colorless transparent liquid, stable in dry air, the water is decomposed into methanol and boric acid, and ethers, tetrahydrofuran, isopropyl amine, n-hexane, methanol and other organic solvent mixture, Specific gravity0.915, Boiling point67-68 ℃, and methanol to form azeotrope.
The global Trimethyl Borate (TMB) market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate…
Global TMB Substrate Kit Market Size,Growth Rate,Industry Opportunities 2023-202 …
Global Info Research announces the release of the report "Global TMB Substrate Kit Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.…
Trimethyl Borate (TMB) Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Trimethyl Borate (TMB) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Trimethyl Borate (TMB) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
